WallStreetZenWallStreetZen

NASDAQ: NTLA
Intellia Therapeutics Inc Stock Ownership - Who owns Intellia Therapeutics?

Insider buying vs selling

Have Intellia Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Eliana ClarkEVP Chief Technical Officer2024-03-04605$32.99
$19.96kSell
James BastaEVP General Counsel2024-03-042,297$32.99
$75.78kSell
Laura SepplorenzinoEVP Chief Scientific Officer2024-01-081,608$28.66
$46.09kSell
Laura SepplorenzinoEVP Chief Scientific Officer2024-01-08667$29.38
$19.60kSell
Eliana ClarkEVP Chief Technical Officer2024-01-03307$30.12
$9.25kSell
James BastaEVP General Counsel2024-01-033,805$29.46
$112.10kSell
Glenn GoddardEVP Chief Financial Officer2024-01-035,365$29.46
$158.05kSell
Derek HicksEVP Chief Business Officer2024-01-033,877$29.46
$114.22kSell
David LebwohlEVP Chief Medical Officer2024-01-035,843$29.46
$172.13kSell
John M. LeonardPresident and CEO2024-01-0319,223$29.46
$566.31kSell

1 of 2

NTLA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NTLA insiders and whales buy or sell their stock.

NTLA Shareholders

What type of owners hold Intellia Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ark Investment Management LLC11.87%11,412,449$308.36MInstitution
Blackrock Inc9.38%9,010,695$243.47MInstitution
Vanguard Group Inc8.69%8,347,449$225.55MInstitution
Caribou Therapeutics Holdco LLC5.82%5,593,846$151.15MInsider
Rachel E. Haurwitz5.82%5,593,846$151.15MInsider
State Street Corp4.93%4,735,861$127.96MInstitution
Novartis Institutes For Biomedical Research Inc4.53%4,352,295$117.60MInsider
Caribou Biosciences Inc4.16%3,994,355$107.93MInsider
Atlas Venture Associates Ix LP3.88%3,729,788$100.78MInsider
Atlas Venture Fund Ix LP3.72%3,579,788$96.73MInsider

1 of 3

NTLA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NTLA68.94%31.06%Net SellingNet Selling
CORT30.65%69.35%Net BuyingNet Buying
MRUS87.00%13.00%Net Buying
RYTM87.97%12.03%Net SellingNet Selling
ALPN59.44%40.56%Net BuyingNet Buying

Intellia Therapeutics Stock Ownership FAQ

Who owns Intellia Therapeutics?

Intellia Therapeutics (NASDAQ: NTLA) is owned by 88.65% institutional shareholders, 39.94% Intellia Therapeutics insiders, and 0.00% retail investors. Caribou Therapeutics Holdco LLC is the largest individual Intellia Therapeutics shareholder, owning 5.59M shares representing 5.82% of the company. Caribou Therapeutics Holdco LLC's Intellia Therapeutics shares are currently valued at $153.89M.

If you're new to stock investing, here's how to buy Intellia Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.